
Actinic keratosis is a chronic skin disease and one of the most common diagnoses in dermatology practices in Europe

The treatment is for adults in combination with atezolizumab

If approved, this would be the first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica

Around 195,000 people globally will be treated for this form of lung cancer in 2026

The treatment is for cerebral adrenoleukodystrophy, a rare neurodegenerative disease

Asthma affects over 360 million people worldwide, including over 40 million people in Europe

The investigational once-weekly oral treatment could be the first long-acting pill for HIV prevention

Gastric cancer is the fifth highest cause of cancer deaths worldwide, with almost a million people diagnosed annually

Up to 50% of allogeneic haematopoietic stem cell transplant patients develop chronic GVHD

The company has invested $40bn in US R&D and manufacturing in the past seven years

The study found significant reductions of major cardiovascular events in high-risk adults following treatment

The treatment is the first and only long-acting HIV prevention option available on the NHS in England and Wales